Circadian Therapeutics

📍 Oxford, United Kingdom🗓 Founded 2016👥 4 employees💰 Last funded Feb 2020
Pharmaceutical Manufacturing🌐 circadiantherapeutics.com
Website LinkedIn
Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and investors. The world-leading science generated by its academic founders is the foundation for the development of therapeutic products based on the understanding of the molecular control of circadian rhythms. With an experienced leadership team and a track-record of building operational capabilities and delivering shareholder value, the Company will develop therapeutics targeting serious diseases associated with circadian rhythm disruption.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Circadian Therapeutics?
Circadian Therapeutics has 2 investors on record on gritt.io, 2 mid-stage.
When did Circadian Therapeutics last raise funding?
The most recent investment in Circadian Therapeutics recorded on gritt.io was in February 2020.
When was Circadian Therapeutics founded?
Circadian Therapeutics was founded in 2016.
What industry is Circadian Therapeutics in?
Circadian Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Circadian Therapeutics based?
Circadian Therapeutics is headquartered in Oxford, United Kingdom.